Priority 9 from the Multiple Sclerosis PSP
| UNCERTAINTY: Which treatments are effective for pain in people with multiple sclerosis? (JLA PSP Priority 9) | |
|---|---|
| Overall ranking | 9 |
| JLA question ID | 0016/9 |
| Explanatory note | Reliable up-to-date systematic reviews have revealed important continuing uncertainties about treatment effects |
| Evidence |
McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD006146. DOI: 10.1002/14651858.CD006146.pub2. |
| Systematic reviews that need extending or updating |
Straube S, Derry S, Moore RA, McQuay HJ. Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD007771. DOI: 10.1002/14651858.CD007771.pub2. O'Connell NE, Wand BM, Marston L, Spencer S, DeSouza LH. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD008208. DOI: 10.1002/14651858.CD008208.pub2. |
| Systematic reviews in preparation |
Cui Y, Zhishun L, Marchese M, Lee MS, Wang J, Niu J. Acupuncture for multiple sclerosis (Protocol). Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD008210. DOI: 10.1002/14651858.CD008210. Accardi MC, Hallquist MN, Jensen MP, Patterson DR, Lynn SJ, Montgomery GH. Clinical hypnosis for chronic pain in adults (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD010691. DOI: 10.1002/14651858.CD010691. |
| Ongoing controlled trials |
None |
| Health Research Classification System category | Neurological |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | No examples provided. This is an indicative uncertainty and several submissions were merged to form this one. |
| Submitted by | 4 patients ~ 1 carer |
| Outcomes to be measured | Management and or change of multiple sclerosis symptoms; adverse effects or complications; acceptability to patients or carers; time to return to work or normal activity; time in hospital and or needing health or social care services; health related quality of life; and costs. |
| PSP information | |
|---|---|
| PSP unique ID | 0016 |
| PSP name | Multiple Sclerosis |
| Total number of uncertainties identified by this PSP. | 82 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | July 2013 |